Speaker Profile
Ph.D., AVP, Amgen
Biography
Dr. Janet Jin is an accomplished leader in precision medicine with nearly 20 years of experience across the pharmaceutical and diagnostics industries. She leads a global multidisciplinary organization focused on advancing biomarker-driven drug development, with expertise spanning clinical diagnostics, imaging, translational pathology, and computational biology across therapeutic areas.
Dr. Jin provides strategic leadership in the development and execution of patient selection, pharmacodynamic, and target engagement biomarker strategies, reverse translation, and the integration of innovative biomarker technology platforms to accelerate drug development and enhance clinical decision-making. She collaborates across cross-functional teams and external partnerships to ensure precision medicine strategies are effectively implemented and aligned with global regulatory requirements.
Earlier in her career, Dr. Jin led oncology assay development efforts advancing next-generation sequencing (NGS)-based liquid biopsy platforms for biomarker discovery and minimal residual disease assessment, contributing to the broader adoption of liquid biopsy technologies and their application in precision oncology.
AI and Data Sciences Showcase:
AtaraxisAI
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
